New study finds early life economic conditions impact risk of type-2 diabetes in adulthood

A new study by current and former FEB researchers Rob Alessie , Viola Angelini , Gerard van den Berg , Jochen Mierau and Gianmaria Niccodemi sheds light on the long-term health implications of economic conditions in early life. The study, titled "Using Data on Biomarkers and Siblings to Study Early-Life Economic Determinants of Type-2 Diabetes," finds a correlation between being born under adverse economic conditions and the onset of type-2 diabetes later in life.
In the introduction to their research paper, the authors highlight the well-established notion that adverse conditions in utero and shortly after birth can negatively affect individual health outcomes in adulthood. Fetuses and newborns are particularly sensitive to stressful environments, with early-life circumstances often "programming" individuals to cope with similar conditions later in life. This programming can lead to detrimental health outcomes over the life cycle, especially when there is a significant discrepancy between early-life and later-life environments, such as being born into poverty but living in an affluent society in adulthood.
Utilizing rich data from Lifelines
The research project, a close collaboration between the Faculty of Economics and Business of the University of Groningen and Lifelines, utilizes data from Lifelines, one of Europe's largest population-based biobanks and cohort studies. Lifelines, renowned for its comprehensive collection of health-related data from over 167,000 individuals in the northern regions of the Netherlands, provides a rich dataset for researchers to investigate various aspects of health and disease across multiple generations.
Using biomarkers to identify diabetes
An important methodological contribution of the study includes the innovative use of biomarkers to identify type-2 diabetes case, enabled by Lifelines’ collection of blood samples. Biomarkers are naturally occurring molecules, genes, or characteristics by which a particular pathological or physiological process, disease, et cetera can be identified. Type-2 diabetes is severely under-diagnosed in the population. Many of those who are affected are unaware of having this condition, leading to underreporting in survey data. In particular, individuals with lower socio-economic status may consult doctors less systematically, and the disease may be asymptomatic in younger and prime-aged individuals. The use of biomarkers allows the authors to detect type-2 diabetes even when people themselves do not realize they have it. Additionally, the research employs a sibling fixed-effects econometric model to address potential selective fertility issues, ensuring robust results.
This study offers valuable insights for policymakers and healthcare professionals striving to address the complex interplay between socioeconomic factors and health outcomes. Understanding the enduring impact of early life experiences on adult health is crucial for developing targeted interventions aimed at reducing the burden of chronic diseases like type-2 diabetes. In this way, the prevention of type-2 diabetes might even be able to start before birth.
More information
The study, "Using Data on Biomarkers and Siblings to Study Early-Life Economic Determinants of Type-2 Diabetes" is now available online at Health Economics.
For further information, please contact Jochen Mierau.
Last modified: | 27 February 2024 10.40 a.m. |
More news
-
20 May 2025
From oyster mushroom to overalls
A T-shirt made from fungi — or mycelium textile, to be more exact. It would be a great step toward a more sustainable fashion industry. At least it could be if the material could be developed in such a way that it can be used for clothing and if...
-
08 May 2025
KNAW appoints three professors of UG/UMCG as new members
Professors Jingyuan Fu, Lisa Herzog, and Helga de Valk of the UG have been appointed members by the Royal Netherlands Academy of Arts and Sciences (KNAW).
-
08 May 2025
6 million euro for large-scale northern project on sustainable healthcare: Care2Change
Care2Change. A large consortium with just about all northern hospitals, local governments, knowledge institutions such as the University of Groningen and the Hanze university of Applied Sciences, and a number of healthcare companies, will cooperate...